Planet 13 Holdings (PLNH) Interest Expenses (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Interest Expenses of $107.5 million for Q1 2026, up 5878.59% year-over-year from $1.8 million in Q1 2025, and up 2156.36% quarter-over-quarter from -$5.2 million in Q4 2025.
Planet 13 Holdings (PLNH) Interest Expenses (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Interest Expenses for 6 consecutive years, with $107.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 5878.59% year-over-year to $107.5 million; the TTM figure through Mar 2026 stood at $107.5 million (up 145184.3% YoY), while the FY2025 annual figure was $64.8 million, up 127.68% from the prior year.
- Interest Expenses grew to $107.5 million in Q1 2026 per PLNH's latest filing, from -$5.2 million in the prior quarter.
- Across five years, Interest Expenses topped out at $107.5 million in Q1 2026 and bottomed at -$5.2 million in Q4 2025.
- Historically, Interest Expenses has averaged $29.9 million across 5 years, with a median of $8.5 million in 2024.
- Annual changes were most pronounced in 2024 — Interest Expenses slumped 455.45% — and 2026, when it soared 5878.59%.
- Planet 13 Holdings' Interest Expenses stood at $1.1 million in 2022, then retreated by 1.18% to $1.1 million in 2023, then plunged by 455.45% to -$3.8 million in 2024, then plunged by 38.43% to -$5.2 million in 2025, then soared by 2156.36% to $107.5 million in 2026.
- Business Quant data shows PLNH's Interest Expenses at $107.5 million in Q1 2026, -$5.2 million in Q4 2025, and $67.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Planet 13 Holdings | 46.72 Mn | 30.24 Mn | 12.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.67 Mn |
| Jun 30, 2026 | 105.67 Mn |
| Mar 31, 2026 | 107.50 Mn |
| Mar 31, 2026 | 107.50 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Sep 30, 2025 | 67.00 Mn |
| Sep 30, 2025 | 67.00 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | -3.78 Mn |
| Dec 31, 2024 | -3.78 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Mar 31, 2024 | 989,887.00 |
| Mar 31, 2024 | 989,887.00 |